A 62-year-old man with type 2 diabetes, chronic kidney disease (eGFR 50 mL/min/1.73 m²) and a recent non-ST-elevation myocardial infarction is already...

Question

A 62-year-old man with type 2 diabetes, chronic kidney disease (eGFR 50 mL/min/1.73 m²) and a recent non-ST-elevation myocardial infarction is already on maximum tolerated metformin and ACE inhibitor therapy. His HbA1c is 7.5%. What additional glucose-lowering agent is MOST appropriate to reduce his cardiovascular and renal risk?

Accepted Answer

Add an SGLT2 inhibitor such as empagliflozin

Answer

Add a sulfonylurea

Answer

Add a DPP-4 inhibitor

Answer

Add basal insulin only

Answer

No additional therapy is needed as HbA1c is acceptable

au-racp MCQ (SBA): Type 2 diabetes with cardiovascular disease